INS and obesity due to melanocortin 4 receptor deficiency: Disadvantages of subcutaneous administration of insulin are hypoglycemia [7], peripheral hyperinsulinemia [8], lipoatrophy, lipohyperatrophy [9], obesity due to intensive therapy [10], insulin neuropathy and insulin presbyopia.